Results per Page:
A promising antibody-drug conjugate for treating brain metastases in breast cancer patients
From the Hurvitz Lab, Clinical Research Division
A new era of COVID-19 brings new outlooks for cellular therapy recipients
From the Liu Group, Vaccine and Infectious Disease Division
Reactivating interest in HSV shedding after solid organ transplant.
From the Johnston, Green and Pergam Labs, Vaccine and Infectious Disease Division
Reconsidering how to assess HSV-2 vaccine responses
From the Corey lab, Vaccine and Infectious Disease Division
Cell free DNA profiling may unlock the key to studying small cell lung cancer
MacPherson and Ha Labs in the Division of Human Biology
Indels: not merely a nuisance in protein evolution
From the Malik Lab in the Division of Basic Science at Fred Hutch and Tenthorey Lab at UCSF
Two steps forward, one step back for targeting NKG2D in cancer treatment
From the Strong Lab in the Basic Sciences Division
Getting the DURT on T cell responses to Mycobacterium tuberculosis
From the Seshadri Lab as a part of the Cancer Consortium Support Grant
From Precancer to Prevention
From Drs. Ming Yu, William Grady and Neelendu Dey
All eyes on IL-6 when it comes to CMV reactivation after bone marrow transplantation
From the Hill Lab in Translational Sciences and Therapuetics Division
A tale of two T cells in Merkel Cell Carcinoma
From the Newell Lab, Vaccines and Infectious Disease Division
A shot for every limb: how splitting up the HIV vaccine may increase immunogenicity
HIV Vaccine Trials Network (HVTN)
Hard to swallow? RORγt expression in Tregs may not regulate oral tolerance, as previously hypothesized.
From the Kublin Lab, Vaccine and Infectious Disease Division
When it comes to HPV vaccination, just once is enough
Galloway Lab, Human Biology Division
The ins and outs of calcium during wound healing
From the Parkhurst Lab, Basic Sciences Division
Investigating CMV reactivation in CARTx patients reveals high risk patients
From the Hill lab, Vaccine and Infectious Disease, Clinical Research and Translational Sciences and Therapeutics Divisions
A niche topic: understanding the development of hematopoietic stem cells
From the Hadland and Bernstein labs, Translational Science and Therapeutics Division